Skip to main content
Erschienen in: BMC Infectious Diseases 1/2024

Open Access 01.12.2024 | Research

Investigating factors associated to HBV/HIV co-infected patients in antiretroviral treatment clinic, in Northeast Ethiopia

verfasst von: Yitbarek Wasihun, Desalegn Asnake, Natnael Kebede

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2024

Abstract

Background

Existing research in Ethiopia has primarily focused on the individual epidemiology of HIV and HBV, often overlooking the intricate dynamics of co-infection. This study aims to address this gap by comprehensively exploring the prevalence of HBV and HIV co-infection and the associated factors influencing co-infection rates within the specific context of ART clinics. The existing study provides limited insights into the unique challenges posed by this dual infection in the Ethiopian population receiving ART.

Methods

An institutional-based cross-sectional study was conducted among people living with HIV aged 18 years and above attending ART clinics in northeast Ethiopia from April to May 2022. A sample size of 350(97% response rate) participants was selected by using a systematic random sampling method. Data were collected using a pre-tested interviewer-administered structured questionnaire. Data was entered into Epi Data version software and was exported to SPSS version 25 for further analysis. Descriptive statistics using Frequency, proportion, and summary measures were done. Binary logistic regressions were done to identify independent variables associated with HBV infection among HIV patients. A P-value less than 0.05 and adjusted odds ratio with a 95% confidence interval non-inclusive of one was considered statistically significant.

Results

The prevalence of Hepatitis B Surface Antigen (HBsAg) was identified constituting 7.14% of the study population. Females [AOR] 0.14; 95% Confidence Interval [CI] [0.041–0.478]). Participants with an educational status of only reading and writing (AOR 8.7; 95% CI [1.143–66.5]). Single individuals (AOR 2.04; 95% CI [1.346–28.6]) were associated factors. Moreover, participants with a viral load exceeding 1000 copies/ml were 6.5 times more likely to be infected with HBV compared to those with undetectable viral loads (AOR 6.53, 95% CI [1.87–22.72]). Additionally, individuals with a CD4 count ranging from 351 to 500 cells/ml were 1.2 times more likely to be infected with HBV compared to those with a CD4 count of 500 cells/ml or above (AOR 10.4, 95% CI [1.28-85]).

Conclusion

The prevalence of HBV infection was found to be intermediate in HIV-infected patients in the study area. Being male, marital status of single and divorced, educational level was only read and written, current viral load of > 1000 copies/ml &<1000 copies/ml, and current CD4 < 250 cells/ml were found statistically associated factors for HBV infection. Thus, we recommend the provision of routine screening for HBsAg and appropriate treatment with accurate information on risk factors for HBV to improve quality of life and reduce morbidity.
Begleitmaterial
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12879-024-09355-4.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

The common transmission route for HBV and HIV underscores the prevalence of co-infection. Viral hepatitis, with its tendency to induce inflammation and damage to liver tissue, further emphasizes the interconnected challenges posed by these concurrent infections [1]. Among the various types of hepatitis viruses (A, B, C, D, E, and G), Hepatitis B stands out as the most severe form, capable of progressing to chronic liver disease and, in severe cases, resulting in mortality [2].
Worldwide, approximately 240 million people are affected by HBV, with the highest prevalence observed in East Asia and sub-Saharan Africa (SSA) [3]. Sub-Saharan Africa (SSA) is also recognized for having the largest population of people living with HIV (PLWHIV) [4]. Additionally, it accounts for 12% of hospital admissions and 31% of mortality in medical wards, attributed to conditions such as viral hepatitis, chronic viral hepatitis, cirrhosis of the liver, and hepatocellular carcinoma [5].
Several factors have been identified as potential risk factors for HBV and HIV co-infection, including socio-demographic factors such as age, sex, monthly income, educational level, marital status, place of residence, current occupational status, health-related factors such as history of blood transfusion, multiple sexual partner, CD4 count, surgical history, OIs, history of hospital admission, history of STDs/STIs, viral load status, cultural factors such as tattoo on the body, ear piercing, and tooth extraction, and behavioral factors such as smoking and alcohol drinking [68].
Existing research in Ethiopia has primarily focused on the individual epidemiology of HIV and HBV, often overlooking the intricate dynamics of co-infection. This study aims to address this gap by comprehensively exploring the prevalence of HBV and HIV co-infection and the associated factors influencing co-infection rates within the specific context of ART clinics. The existing study provides limited insights into the unique challenges posed by this dual infection in the Ethiopian population receiving ART.

Methods and materials

Study area, period, and study design

A cross-sectional study was undertaken from April to May 2022in the South Wollo zone of northeast Ethiopia health centuries. South Wollo zone is situated 401 km from Addis Ababa, Ethiopia’s capital [9].

Population

The source population consisted of all HIV-positive patients attending ART clinics at the Health Center in the South Wollo zone, northeast Ethiopia. The study population comprised randomly selected HIV-positive patients attending ART clinics at the same health center during the study period. Specifically, the study included HIV-positive patients with follow-ups at the ART clinic in the South Wollo zone, northeast Ethiopia. Critically ill individuals who were unable to communicate during data collection were excluded from the study.

Sample size, sampling procedures, and techniques

The Sample size based on the first specific objective was determined by using a formula for estimating a single population proportion and assuming a confidence interval of 95%, marginal error of 3%, and considering 8.4% proportion of HBV infection among HIV patients [10]. By adding a 10% non-response rate, the final sample size became 361. So, the final sample size was taken at 361 which is calculated for the prevalence.
The sample size was determined using Epi info version 7 by taking the assumptions of 95% confidence level, 3% margin of error, 80% power, taking the percent of outcome exposed from previous studies, and 10% non-response reveals result as presented below (Table 1).
Table 1
Sample size for factors HBsAg status of HIV-positive adults who are attending ART Clinic Northeast Ethiopia, 2022
Variables
Proportion of outcome among
OR
Sample size
Final sample size (10% for non-response)
Citation
Exposed
Unexposed
Multiple
sexual partner
19.2
5.2
4.3
198
218
(39)
Marital status
(Single )
12.3
1.2
14.75
146
161
(23)
CD4 count ≤
200/cells/ml
18.1
3.2
6.7
158
174
(30)
Participants were chosen through a systematic sampling technique, with the initial respondents identified using a random method. The allocation of sample sizes to health facilities was proportional to the average number of patients per month at each respective health facility.

Data collection tools, procedure, and Data quality assurance

Structured questionnaires, developed through a review of previous literature, were employed for data collection. The questionnaire, translated into the local language, predominantly featured closed-ended questions. A team of 3 BSc nurses and 2 laboratory technicians conducted data collection. Both data collectors and supervisors underwent a one-day training session covering the study’s objectives, questionnaire content, data collection procedures, participant assistance, and ethical considerations. A pre-test was conducted with 5% of participants at Borumeda Hospital’s ART clinic, leading to necessary questionnaire modifications. Continuous close supervision was maintained by both supervisors and the principal investigator throughout the study.
Standardized procedures were rigorously adhered to during blood sample collection, storage, and the analytical process. Test results were interpreted and reported as positive or negative according to the manufacturer’s instructions. Confirmation of HBsAg positive serum samples was carried out using a 3rd generation ELISA assay at Amhara Regional Red Cross Laboratory, Dessie branch. Throughout the data collection period, the principal investigator and supervisors diligently checked the collected data daily to ensure completeness.

Data processing and analysis

The data were inputted into Epi Data version 4.4.2.1 Software and subsequently exported to SPSS version 25 for further analysis. Descriptive statistics, including frequency, proportion, and summary measures, were computed. For identifying statistically significant factors associated with HBV/HIV co-infection, a binary logistic regression model was employed.
Initially, a bi-variable binary logistic regression analysis was conducted for each independent variable against the outcome variable. Variables with a P-value less than 0.2 in this analysis were then included in the final model for multivariable binary logistic analysis regression. In the multivariable binary logistic regression analysis, variables with a P-value less than 0.05 and a 95% confidence interval that did not cross one were deemed statistically significant. To assess the model’s fitness, the Hosmer and Lemeshow goodness-of-fit test was employed.

Results

Socio-demographic characteristics of the respondents

A total of 350 participants took part in the study, yielding a robust response rate of 97%. The demographic profile revealed that a majority of the study participants were male, accounting for 56.3%, and the majority 45.4% of the participants were felled in the ages of 28–37. In terms of marital status, over two-thirds of the participants, comprising 68% were married, while 66 individuals (18.9%) reported being divorced.
Educational backgrounds varied, with 31.7% of participants unable to read and write, 21.1% completing primary education, and 8% having a secondary school education. (Table 2).
Table 2
Socio-demographic characteristics of HIV-positive adults who are attending ART Clinic Northeast Ethiopia, 2022
Variables
Frequency
Percentage (%)
Sex
  
Male
197
56.3
Female
153
43.7
Age
  
18–27
27
7.7
28–37
159
45.4
38–47
128
36.6
≥ 48
36
10.3
Marital status
  
Married
238
68
Single
46
13.1
Divorced
66
18.8
Widowed
0
0%
Education Status
  
Unable to read and write
116
33.1
Read and write
111
31.7
Primary
77
22
Secondary
28
8
College and above
18
5.1
Monthly income
  
< 500
19
3.8
500–1000
33
9.4
 1000–1500
162
46.2
 1500–2000
84
24
 2000–2500
19
5.4
> 2500
33
9.4
Place of residence
  
Urban
151
43.1
Rural
199
46.9
The majority of participants in the study exhibited encouraging outcomes regarding viral load, with 42.6% with viral loads below 1000 copies/ml. However, 16.3% of participants had viral loads equal to or exceeding 1000 copies/ml, suggesting a significant portion of the cohort may require closer monitoring or intervention. Regarding risky behaviors, a notable 69.8% reported engaging in multiple sexual partners. Additionally, while the majority (77.4%) reported no history of blood transfusion.
The majority of participants in the study reported a positive history of sharing sharp instruments, with 13.5% acknowledging this behavior. Furthermore, 27.3% of participants had a family history of HBV. Additionally, a substantial proportion (32.7%) reported undergoing dental extraction. Notably, a majority of participants (69.3%) had a history of opportunistic infections (OIs. Moreover, 41.7% reported a history of sexually transmitted infections (STIs)(Table 3).
Table 3
Health-related, cultural characteristics and their HBsAg status of HIV-positive adults who are attending ART Clinic Northeast Ethiopia, 2022
Variables
Frequency
Percentage
Viral load
  
No detectable
144
41.1
< 1000 copies/ml
149
42.6
≥ 1000 copies/ml
57
16.3
Multiple sexual
  
No
106
30.2
Yes
244
69.8
Blood transfusion
  
NO
271
77.4
YES
79
22.6
Regular sexual partner
  
NO
141
40.3
YES
209
59.7
Hospital admission
  
NO
289
82.6
YES
61
17.4
Surgical history
  
NO
272
77.7
YES
78
22.3
Awareness about HBV prevention
  
NO
289
82.6
YES
61
17.4
Family history of HBV
  
NO
279
72.7
YES
71
27.3
Sharing sharp Instrument
  
NO
303
86.5
YES
47
13.5
Dental extraction
  
NO
237
67.7
YES
113
32.3
Ear piercing
  
NO
212
60.6
YES
138
39.4
History of OIs
  
NO
111
31.7
YES
239
69.3
History of STI
  
NO
169
48.3
YES
181
41.7
CD4 count
  
< 200
125
35.7
200–350
94
26.8
351–500
94
26.8
> 500
37
10.7

Factor associated with HBV/HIV co-infection

In bivariate analysis namely sex, viral load, history of blood transfusion, educational level, regular sexual partner, multiple sexual practices, hospital admission, surgical history, Awareness about HBV prevention, family history of HBV, sharing of sharp instrument, place of residence, marital status and CD4 count were selected for the multiple logistic regression analysis based on a p-value of < 0.2. The fitness of the model was checked by the Hosmer and Lemeshow goodness of fit test. Accordingly, the model was considered fit if it was found to be insignificant (p > 0.05) based on the fit test. The Hosmer and Lemeshow goodness-of-fit test yielded a p-value of 0.08, indicating a good fit of the model to the observed data.
Start within the multiple logistic regressions namely sex, educational status, viral load, marital status surgical history, and CD4 count) were significantly associated with HIV-HBV co-infection, then The analysis revealed that females were 0.14 times less likely to be infected with HBV co-infection compared to males, with an 86% reduction in the odds of HBV infection [AOR = 0.14; 95% CI: 0.041, 0.478]. Participants with the educational status of only reading and writing were 8.7 times more likely to be infected with HBV than college and above [AOR = 8.7; 95% CI: 1.143, 66.5]. Participants having marital status of single were 2 times more likely to be infected with HBV than married [AOR = 2.04; 95% CI: 1.346, 28.6].
Participants having a surgical history of 0.206 were less likely to have HBV/HIV Co-infection as compared to those who did not [AOR = 0.206; 95% CI: 0.057,0.746]. Participants with educational status categorized as unable to read and write or only able to read and write were respectively 7.8 and 8.7 times more likely to be infected with HBV compared to those with a college education or higher [AOR = 7.8; 95% CI: 1.3, 62.3] and [AOR = 8.7; 95% CI: 1.14, 66.4] respectively. Participants having CD4 count 351–500 cells/ ml were 10.4 times more likely to be infected with HBV than CD4 count > = 500 cells/ [AOR = 10.4; 95% CI: 1.28,85]. Participants having viral load < = 1000 copies/ml were 16.2 times more likely to be infected with HBV than viral load not detectable [AOR = 16.53; 95% CI: 3.6, 72.59]. Participants who had viral load > 1000 copies/ml were 6.53 times more likely to be infected with HBV than viral load not detectable [AOR = 6.53; 95% CI: 1.87, 22.72]. Moreover, participants with a history of surgical procedures exhibited significantly lower odds of HBV infection [AOR = 0.15; 95% CI: 0.43–0.49] (Table 4).
Table 4
Risk factors associated with Hepatitis B surface antigen from bivariable and multivariable logistic regression analysis, among HIV Positive adults attending ART clinic Northeast Ethiopia, 2022
Variables
HBV
COR(95% CI)
AOR(95%CI)
Yes
No
Sex
    
 Female
5
148
0.29(0.11–0.82)
0.14 (0.41–0.48) *
 Male
20
177
1
1
Educational status
    
 Unable to read and write
3
113
6.28(1.175–33.54)
7.8(1.1–62.3)*
 Only read and write
6
105
2.92(0.66,-12.7)
8.7(1.14–66.4)*
 Primary school
10
64
1.07(0.26–4.29)
1.14(0.199–6.23)
 Secondary school
3
25
1.38(0.251–7.68)
1.08(0.13–8.5)
 College and above
3
18
1
1
Viral load
    
 No detectable
5
139
1
1
 ≤ 1000 copies/ml
9
140
6.65(2.19–20.1)
16.12(3.6–72.5)*
 > 1000 copies/ml
11
46
3.75(1.45–9.54)
6.53(1.87–22.72)*
Marital status
    
 Married
9
229
1
1
 Single
7
39
4.02(1.53–10.58)
2.04(1.346–28.6)*
 Divorced
9
57
0.88(0.32–2.56)
2.59(0.56–11.95)
Surgical history
    
 NO
11
261
1
1
 YES
14
64
0.19(0.08–0.44
0.15(0.43–0.49)*
CD4 count
    
 < 200
12
113
1.823(0.633–5.247)
0.942(0.176-5.1)
 200–350
5
89
1.02(0.363–2.86)
1.58(0.28–8.89)
 351–500
2
92
1.21(0.421–3.45)
10.4(1.28-85)*
 > 500
6
31
1
1
N.B.*Statistically Significant p < 0.05.

Discussion

The study revealed an overall HBV/HIV co-infection rate of 7.14%, indicating a moderate public health concern among adults living with HIV on antiretroviral therapy in the study area. Significant associations with co-infection were found for females, viral load exceeding 1000 copies/ml, single marital status, educational level unable to read and write or read and write, CD4 count between 351 and 500 cells/ml and surgical history. This prevalence closely aligns with other studies, such as the one conducted in Addis Ababa Public Hospital, which reported a comparable 7.3% co-infection rate [10]. Goba general hospital 7.4% [11]and Gondar 7.3% [12]. On the other hand, this study’s finding is higher than the study conducted in Hawassa referral hospital 6.9% [13].HBsAg prevalence from this study is also in agreement with previous studies conducted among HIV-positive adults in India 8.35 [14] and Ghana 8.8 [15]. This difference might be due to the accessibility of information about the mode of transmission and prevention as can be seen from the proportion of participants with poor knowledge scores in this study.
In the present study significant association has been found between HBsAg positivity and gender other studies done in the country from ART centers [16], females were found to have less HBsAg positivity and the study revealed that females were 0.14 times Less likely to have HBV/HIV co-infection than male. The possible explanation could be, that in developing countries, like Ethiopia because of their job nature, males travel more frequently than females. Those who have viral load < 1000 copies/ml were about more likely to have HBV/HIV Co-infection as compared to viral load not detectable, followed by Those who have viral load > 1000 copies/ml were about more likely to have HBV/HIV Co-infection. The association might be because HIV patients who have HBV/HIV co-infection have weaker immunity than those who have not HBV/HIV co-infected HIV patients which will make them more prone to increased viral load [17]. This study revealed that a significantly high prevalence of HBV/HIV co-infection was observed among individuals with a marital status of single who are more likely to have HBV/HIV co-infection than those married. This is because patients having marital status, and single most of the time have a history of multiple sexual practices which can lead to increased HBV/HIV co-infection [13]. Regarding HBV infection, even though, studies from Debretabor Hospital [18] and Mekelle Hospital [16], showed no significant association between marital status and history of surgery with HBV infection.

Conclusion

In this study area, the prevalence of HBV infection was found to be moderate in HIV-infected patients. Furthermore, this study it was also observed a greater HBV Prevalence among males, individuals having viral load > 1000 copies/ml, individuals who were single and divorced, a history of surgery, and educational status who were only read and written were found statistically associated factors for HBV infection.

Acknowledgements

We are grateful to thank the Institutional Review Board of the college of Zemen Postgraduate, Dessie, Ethiopia. Also, we want to gratify study participants and data collectors.

Declarations

Competing interests

The authors declare no competing interests.
Ethical approval was obtained from the Institutional Review Board of the college of Zemen Postgraduate, Dessie, Ethiopia. After explaining the purpose of the study, written informed consent was obtained from participants before data collection. They were informed that participating in the study was voluntary and their right to withdraw from the study at any time during the interview was assured. For this purpose, a one-page consent letter was attached as a cover page of each questionnaire stating the general objective of the study and issues of confidentiality. All methods and materials were performed according to the guidelines.
Not applicable.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anhänge

Electronic supplementary material

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Johnson NB, Hayes LD, Brown K, Hoo EC, Ethier KA. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors—United States, 2005–2013. 2014. Johnson NB, Hayes LD, Brown K, Hoo EC, Ethier KA. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors—United States, 2005–2013. 2014.
2.
Zurück zum Zitat Roshandel G, Semnani S, Abdolahi N, Besharat S, Keshtkar A-A, Joshaqani H, et al. Prevalence of hepatitis D virus infection in hepatitis B surface antigen-positive subjects in Golestan Province, northeast Iran. J Microbiol Immunol Infect. 2008;41(3):227–30.PubMed Roshandel G, Semnani S, Abdolahi N, Besharat S, Keshtkar A-A, Joshaqani H, et al. Prevalence of hepatitis D virus infection in hepatitis B surface antigen-positive subjects in Golestan Province, northeast Iran. J Microbiol Immunol Infect. 2008;41(3):227–30.PubMed
3.
Zurück zum Zitat Organization WH. Hepatitis b fact sheet, no 204 [updated July 2015]. Geneva, Switzerland: World Health Organization; 2013. Organization WH. Hepatitis b fact sheet, no 204 [updated July 2015]. Geneva, Switzerland: World Health Organization; 2013.
4.
Zurück zum Zitat Case KK, Gregson S, Mahy M, Ghys PD, Hallett TB. Methodological developments in the Joint United Nations Programme on HIV/AIDS estimates. AIDS. 2017;31:S1–4.CrossRefPubMed Case KK, Gregson S, Mahy M, Ghys PD, Hallett TB. Methodological developments in the Joint United Nations Programme on HIV/AIDS estimates. AIDS. 2017;31:S1–4.CrossRefPubMed
5.
Zurück zum Zitat Keers RN, Williams SD, Cooke J, Ashcroft DM. Causes of medication administration errors in hospitals: a systematic review of quantitative and qualitative evidence. Drug Saf. 2013;36:1045–67.CrossRefPubMedPubMedCentral Keers RN, Williams SD, Cooke J, Ashcroft DM. Causes of medication administration errors in hospitals: a systematic review of quantitative and qualitative evidence. Drug Saf. 2013;36:1045–67.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Hlophe LD, Tamuzi JL, Shumba C, Nyasulu PS. Barriers to anti-retroviral therapy adherence among adolescents aged 10 to 19 years living with HIV in sub-saharan Africa: a mixed-methods systematic review protocol. PLoS ONE. 2022;17(9):e0273435.CrossRefPubMedPubMedCentral Hlophe LD, Tamuzi JL, Shumba C, Nyasulu PS. Barriers to anti-retroviral therapy adherence among adolescents aged 10 to 19 years living with HIV in sub-saharan Africa: a mixed-methods systematic review protocol. PLoS ONE. 2022;17(9):e0273435.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Jones JM, Kracalik I, Levi ME, Bowman JS III, Berger JJ, Bixler D, et al. Assessing solid organ donors and monitoring transplant recipients for human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection—US. Public Health Service Guideline 2020 MMWR Recommendations Rep. 2020;69(4):1. Jones JM, Kracalik I, Levi ME, Bowman JS III, Berger JJ, Bixler D, et al. Assessing solid organ donors and monitoring transplant recipients for human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection—US. Public Health Service Guideline 2020 MMWR Recommendations Rep. 2020;69(4):1.
8.
Zurück zum Zitat Khetsuriani N, Mosina L, Van Damme P, Mozalevskis A, Datta S, Tohme RA. Progress toward Hepatitis B Control—World Health Organization European Region, 2016–2019. Morb Mortal Wkly Rep. 2021;70(30):1029.CrossRef Khetsuriani N, Mosina L, Van Damme P, Mozalevskis A, Datta S, Tohme RA. Progress toward Hepatitis B Control—World Health Organization European Region, 2016–2019. Morb Mortal Wkly Rep. 2021;70(30):1029.CrossRef
9.
10.
Zurück zum Zitat Goa A, Dana T, Bitew S, Arba A. Seroprevalence and associated factors of hepatitis B virus infection among HIV-positive adults attending an antiretroviral treatment clinic at Wolaita Sodo University Referral Hospital. Hepatic Medicine: Evid Res. 2019;137:47. Goa A, Dana T, Bitew S, Arba A. Seroprevalence and associated factors of hepatitis B virus infection among HIV-positive adults attending an antiretroviral treatment clinic at Wolaita Sodo University Referral Hospital. Hepatic Medicine: Evid Res. 2019;137:47.
11.
Zurück zum Zitat Erena AN, Tefera TB. Prevalence of hepatitis B surface antigen (HBsAg) and its risk factors among individuals visiting Goba General Hospital, South East Ethiopia, 2012. BMC Res Notes. 2014;7(1):1–5.CrossRef Erena AN, Tefera TB. Prevalence of hepatitis B surface antigen (HBsAg) and its risk factors among individuals visiting Goba General Hospital, South East Ethiopia, 2012. BMC Res Notes. 2014;7(1):1–5.CrossRef
12.
Zurück zum Zitat Wondimeneh Y, Alem M, Asfaw F, Belyhun Y. HBV and HCV seroprevalence and their correlation with CD4 cells and liver enzymes among HIV positive individuals at University of Gondar Teaching Hospital, Northwest Ethiopia. Virol J. 2013;10:1–8.CrossRef Wondimeneh Y, Alem M, Asfaw F, Belyhun Y. HBV and HCV seroprevalence and their correlation with CD4 cells and liver enzymes among HIV positive individuals at University of Gondar Teaching Hospital, Northwest Ethiopia. Virol J. 2013;10:1–8.CrossRef
13.
Zurück zum Zitat Belayneh F. Prevalence of hepatitis B virus infection and associated factors among HIV positive adults attending ART clinic at Hawassa referral hospital, SNNPR, Ethiopia. Open Access Libr J. 2015;2(05):1. Belayneh F. Prevalence of hepatitis B virus infection and associated factors among HIV positive adults attending ART clinic at Hawassa referral hospital, SNNPR, Ethiopia. Open Access Libr J. 2015;2(05):1.
14.
Zurück zum Zitat Xie J, Han Y, Qiu Z, Li Y, Li Y, Song X, et al. Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross‐sectional study. J Int AIDS Soc. 2016;19(1):20659.CrossRefPubMedPubMedCentral Xie J, Han Y, Qiu Z, Li Y, Li Y, Song X, et al. Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross‐sectional study. J Int AIDS Soc. 2016;19(1):20659.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Kye-Duodu G, Nortey P, Malm K, Nyarko KM, Sackey SO, Ofori S et al. Prevalence of hepatitis B virus co-infection among HIV-seropositive persons attending antiretroviral clinics in the Eastern Region of Ghana. Pan Afr Med J. 2016;25(Suppl 1). Kye-Duodu G, Nortey P, Malm K, Nyarko KM, Sackey SO, Ofori S et al. Prevalence of hepatitis B virus co-infection among HIV-seropositive persons attending antiretroviral clinics in the Eastern Region of Ghana. Pan Afr Med J. 2016;25(Suppl 1).
16.
Zurück zum Zitat Weldemhret L, Asmelash T, Belodu R, Gebreegziabiher D. Sero-prevalence of HBV and associated risk factors among HIV positive individuals attending ART clinic at Mekelle hospital, Tigray, Northern Ethiopia. AIDS Res Therapy. 2016;13(1):1–7.CrossRef Weldemhret L, Asmelash T, Belodu R, Gebreegziabiher D. Sero-prevalence of HBV and associated risk factors among HIV positive individuals attending ART clinic at Mekelle hospital, Tigray, Northern Ethiopia. AIDS Res Therapy. 2016;13(1):1–7.CrossRef
17.
Zurück zum Zitat Matthews PC, Geretti AM, Goulder PJ, Klenerman P. Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-saharan Africa. J Clin Virol. 2014;61(1):20–33.CrossRefPubMed Matthews PC, Geretti AM, Goulder PJ, Klenerman P. Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-saharan Africa. J Clin Virol. 2014;61(1):20–33.CrossRefPubMed
18.
Zurück zum Zitat Balew M, Moges F, Yismaw G, Unakal C. Assessment of Hepatitis B virus and hepatitis C virus infections and associated risk factors in HIV infected patients at Debretabor hospital, South Gondar, Northwest Ethiopia. Asian Pac J Trop Disease. 2014;4(1):1–7.CrossRef Balew M, Moges F, Yismaw G, Unakal C. Assessment of Hepatitis B virus and hepatitis C virus infections and associated risk factors in HIV infected patients at Debretabor hospital, South Gondar, Northwest Ethiopia. Asian Pac J Trop Disease. 2014;4(1):1–7.CrossRef
Metadaten
Titel
Investigating factors associated to HBV/HIV co-infected patients in antiretroviral treatment clinic, in Northeast Ethiopia
verfasst von
Yitbarek Wasihun
Desalegn Asnake
Natnael Kebede
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2024
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09355-4

Weitere Artikel der Ausgabe 1/2024

BMC Infectious Diseases 1/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.